nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—Orlistat—type 2 diabetes mellitus	0.402	1	CbGbCtD
Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.361	1	CbGaD
Fluocinolone Acetonide—PLA2G4A—Glyburide—Tolazamide—type 2 diabetes mellitus	0.000735	0.17	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Glyburide—Glimepiride—type 2 diabetes mellitus	0.000735	0.17	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Glyburide—Glipizide—type 2 diabetes mellitus	0.000697	0.161	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Glyburide—Gliclazide—type 2 diabetes mellitus	0.000697	0.161	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.000638	0.148	CbGdCrCtD
Fluocinolone Acetonide—NR3C1—nerve—type 2 diabetes mellitus	0.000624	0.111	CbGeAlD
Fluocinolone Acetonide—SERPINA6—nephron tubule—type 2 diabetes mellitus	0.000556	0.0993	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Enalapril—Nateglinide—type 2 diabetes mellitus	0.000508	0.118	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—cardiovascular system—type 2 diabetes mellitus	0.000501	0.0895	CbGeAlD
Fluocinolone Acetonide—SERPINA6—kidney—type 2 diabetes mellitus	0.000488	0.0872	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—cortex of kidney—type 2 diabetes mellitus	0.000478	0.0853	CbGeAlD
Fluocinolone Acetonide—SERPINA6—cortex of kidney—type 2 diabetes mellitus	0.000476	0.0849	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—adipose tissue—type 2 diabetes mellitus	0.000442	0.0789	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Enalapril—Ramipril—type 2 diabetes mellitus	0.000309	0.0716	CbGdCrCtD
Fluocinolone Acetonide—SERPINA6—liver—type 2 diabetes mellitus	0.000309	0.0551	CbGeAlD
Fluocinolone Acetonide—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000302	0.054	CbGeAlD
Fluocinolone Acetonide—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000243	0.0435	CbGeAlD
Fluocinolone Acetonide—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000219	0.039	CbGeAlD
Fluocinolone Acetonide—NR3C1—kidney—type 2 diabetes mellitus	0.000214	0.0382	CbGeAlD
Fluocinolone Acetonide—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000214	0.0405	CrCbGaD
Fluocinolone Acetonide—NR3C1—pancreas—type 2 diabetes mellitus	0.000212	0.0379	CbGeAlD
Fluocinolone Acetonide—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000212	0.00139	CcSEcCtD
Fluocinolone Acetonide—Nausea—Acarbose—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Fluocinolone Acetonide—Pain—Glipizide—type 2 diabetes mellitus	0.00021	0.00138	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00021	0.00138	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000209	0.00137	CcSEcCtD
Fluocinolone Acetonide—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000208	0.0372	CbGeAlD
Fluocinolone Acetonide—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000208	0.00137	CcSEcCtD
Fluocinolone Acetonide—Erythema—Gliclazide—type 2 diabetes mellitus	0.000208	0.00137	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000208	0.00137	CcSEcCtD
Fluocinolone Acetonide—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000207	0.0393	CrCbGaD
Fluocinolone Acetonide—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00136	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000206	0.00135	CcSEcCtD
Fluocinolone Acetonide—Infection—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00135	CcSEcCtD
Fluocinolone Acetonide—Nausea—Nateglinide—type 2 diabetes mellitus	0.000203	0.00134	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000203	0.00133	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000203	0.00133	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00133	CcSEcCtD
Fluocinolone Acetonide—Back pain—Gliclazide—type 2 diabetes mellitus	0.000201	0.00132	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Metformin—type 2 diabetes mellitus	0.0002	0.00132	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000198	0.0013	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000198	0.0013	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000198	0.0013	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000197	0.0013	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000196	0.00129	CcSEcCtD
Fluocinolone Acetonide—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000196	0.0372	CrCbGaD
Fluocinolone Acetonide—Desonide—NR3C1—type 2 diabetes mellitus	0.000196	0.0372	CrCbGaD
Fluocinolone Acetonide—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000195	0.00128	CcSEcCtD
Fluocinolone Acetonide—Pain—Sitagliptin—type 2 diabetes mellitus	0.000195	0.00128	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Valsartan—type 2 diabetes mellitus	0.000194	0.00127	CcSEcCtD
Fluocinolone Acetonide—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000193	0.0344	CbGeAlD
Fluocinolone Acetonide—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000192	0.00126	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000192	0.00126	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Orlistat—type 2 diabetes mellitus	0.000191	0.00126	CcSEcCtD
Fluocinolone Acetonide—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000191	0.0363	CrCbGaD
Fluocinolone Acetonide—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000191	0.00126	CcSEcCtD
Fluocinolone Acetonide—Influenza—Ramipril—type 2 diabetes mellitus	0.00019	0.00125	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Orlistat—type 2 diabetes mellitus	0.00019	0.00125	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000189	0.00124	CcSEcCtD
Fluocinolone Acetonide—Oedema—Glyburide—type 2 diabetes mellitus	0.000189	0.00124	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000189	0.00124	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000188	0.00124	CcSEcCtD
Fluocinolone Acetonide—Rash—Repaglinide—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Metformin—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Fluocinolone Acetonide—Fludrocortisone—AR—type 2 diabetes mellitus	0.000186	0.0353	CrCbGaD
Fluocinolone Acetonide—Headache—Repaglinide—type 2 diabetes mellitus	0.000186	0.00122	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000185	0.00122	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Losartan—type 2 diabetes mellitus	0.000185	0.00122	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000185	0.00122	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000185	0.00122	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000185	0.00121	CcSEcCtD
Fluocinolone Acetonide—Back pain—Valsartan—type 2 diabetes mellitus	0.000185	0.00121	CcSEcCtD
Fluocinolone Acetonide—Back pain—Orlistat—type 2 diabetes mellitus	0.000182	0.0012	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000182	0.00119	CcSEcCtD
Fluocinolone Acetonide—Cough—Gliclazide—type 2 diabetes mellitus	0.000181	0.00119	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000181	0.00119	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.00018	0.00118	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00018	0.00118	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Losartan—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Fluocinolone Acetonide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Fluocinolone Acetonide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000176	0.00116	CcSEcCtD
Fluocinolone Acetonide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000176	0.00115	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Metformin—type 2 diabetes mellitus	0.000174	0.00114	CcSEcCtD
Fluocinolone Acetonide—Erythema—Metformin—type 2 diabetes mellitus	0.000174	0.00114	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Glipizide—type 2 diabetes mellitus	0.000174	0.00114	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000173	0.00114	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000172	0.00113	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Valsartan—type 2 diabetes mellitus	0.000171	0.00113	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00017	0.00112	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.00017	0.00112	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Orlistat—type 2 diabetes mellitus	0.000169	0.00111	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000169	0.00111	CcSEcCtD
Fluocinolone Acetonide—Infection—Gliclazide—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000168	0.0011	CcSEcCtD
Fluocinolone Acetonide—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.000167	0.0318	CrCbGaD
Fluocinolone Acetonide—Cough—Valsartan—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Fluocinolone Acetonide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000166	0.00109	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000166	0.00109	CcSEcCtD
Fluocinolone Acetonide—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000165	0.0312	CrCbGaD
Fluocinolone Acetonide—Cough—Orlistat—type 2 diabetes mellitus	0.000165	0.00108	CcSEcCtD
Fluocinolone Acetonide—Erythema—Irbesartan—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Metformin—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Fluocinolone Acetonide—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000162	0.0307	CrCbGaD
Fluocinolone Acetonide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000161	0.00106	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000161	0.00106	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000159	0.00104	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Losartan—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00103	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000156	0.00103	CcSEcCtD
Fluocinolone Acetonide—Oedema—Valsartan—type 2 diabetes mellitus	0.000156	0.00102	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000155	0.00102	CcSEcCtD
Fluocinolone Acetonide—Infection—Valsartan—type 2 diabetes mellitus	0.000155	0.00102	CcSEcCtD
Fluocinolone Acetonide—Rash—Glipizide—type 2 diabetes mellitus	0.000155	0.00102	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000155	0.00102	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000155	0.00102	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000154	0.00102	CcSEcCtD
Fluocinolone Acetonide—Erythema—Losartan—type 2 diabetes mellitus	0.000154	0.00102	CcSEcCtD
Fluocinolone Acetonide—Oedema—Orlistat—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Fluocinolone Acetonide—Headache—Glipizide—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Fluocinolone Acetonide—Infection—Orlistat—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000153	0.001	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000151	0.000996	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000151	0.000994	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000151	0.000993	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000151	0.000992	CcSEcCtD
Fluocinolone Acetonide—Budesonide—NR3C1—type 2 diabetes mellitus	0.000151	0.0286	CrCbGaD
Fluocinolone Acetonide—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000151	0.0286	CrCbGaD
Fluocinolone Acetonide—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000149	0.000982	CcSEcCtD
Fluocinolone Acetonide—Back pain—Losartan—type 2 diabetes mellitus	0.000149	0.000982	CcSEcCtD
Fluocinolone Acetonide—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.000148	0.028	CrCbGaD
Fluocinolone Acetonide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000147	0.000969	CcSEcCtD
Fluocinolone Acetonide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000147	0.000968	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000146	0.000963	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000146	0.000962	CcSEcCtD
Fluocinolone Acetonide—Nausea—Glipizide—type 2 diabetes mellitus	0.000146	0.000958	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000146	0.000957	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Losartan—type 2 diabetes mellitus	0.000145	0.000957	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000145	0.000954	CcSEcCtD
Fluocinolone Acetonide—Pain—Gliclazide—type 2 diabetes mellitus	0.000145	0.000953	CcSEcCtD
Fluocinolone Acetonide—Rash—Glimepiride—type 2 diabetes mellitus	0.000144	0.000949	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000144	0.000948	CcSEcCtD
Fluocinolone Acetonide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000144	0.000946	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000144	0.000945	CcSEcCtD
Fluocinolone Acetonide—Headache—Glimepiride—type 2 diabetes mellitus	0.000143	0.000943	CcSEcCtD
Fluocinolone Acetonide—Mometasone—NR3C1—type 2 diabetes mellitus	0.000143	0.0272	CrCbGaD
Fluocinolone Acetonide—Cough—Irbesartan—type 2 diabetes mellitus	0.000143	0.000941	CcSEcCtD
Fluocinolone Acetonide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000143	0.00094	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000142	0.000933	CcSEcCtD
Fluocinolone Acetonide—Oedema—Metformin—type 2 diabetes mellitus	0.000142	0.000933	CcSEcCtD
Fluocinolone Acetonide—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000142	0.0268	CrCbGaD
Fluocinolone Acetonide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000141	0.000929	CcSEcCtD
Fluocinolone Acetonide—Infection—Metformin—type 2 diabetes mellitus	0.000141	0.000927	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00014	0.000922	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00014	0.000918	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000139	0.000915	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000139	0.000915	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Losartan—type 2 diabetes mellitus	0.000139	0.000912	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000137	0.000901	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000137	0.000898	CcSEcCtD
Fluocinolone Acetonide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000136	0.000894	CcSEcCtD
Fluocinolone Acetonide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000136	0.000891	CcSEcCtD
Fluocinolone Acetonide—NR3C1—liver—type 2 diabetes mellitus	0.000135	0.0241	CbGeAlD
Fluocinolone Acetonide—Cough—Losartan—type 2 diabetes mellitus	0.000135	0.000886	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000134	0.000884	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Ramipril—type 2 diabetes mellitus	0.000134	0.000883	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000134	0.000881	CcSEcCtD
Fluocinolone Acetonide—Oedema—Irbesartan—type 2 diabetes mellitus	0.000134	0.00088	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000134	0.000878	CcSEcCtD
Fluocinolone Acetonide—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000134	0.0253	CrCbGaD
Fluocinolone Acetonide—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000134	0.0253	CrCbGaD
Fluocinolone Acetonide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000133	0.000876	CcSEcCtD
Fluocinolone Acetonide—Infection—Irbesartan—type 2 diabetes mellitus	0.000133	0.000874	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000133	0.000874	CcSEcCtD
Fluocinolone Acetonide—Erythema—Ramipril—type 2 diabetes mellitus	0.000132	0.00087	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000132	0.00087	CcSEcCtD
Fluocinolone Acetonide—Pain—Orlistat—type 2 diabetes mellitus	0.000132	0.000865	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000131	0.000864	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000131	0.000864	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000131	0.000863	CcSEcCtD
Fluocinolone Acetonide—Rash—Bromocriptine—type 2 diabetes mellitus	0.00013	0.000856	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00013	0.000856	CcSEcCtD
Fluocinolone Acetonide—Alclometasone—NR3C1—type 2 diabetes mellitus	0.00013	0.0246	CrCbGaD
Fluocinolone Acetonide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00013	0.000852	CcSEcCtD
Fluocinolone Acetonide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000129	0.000851	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000129	0.00085	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000129	0.000849	CcSEcCtD
Fluocinolone Acetonide—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000126	0.024	CrCbGaD
Fluocinolone Acetonide—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000126	0.024	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—NR3C1—type 2 diabetes mellitus	0.000126	0.024	CrCbGaD
Fluocinolone Acetonide—Oedema—Losartan—type 2 diabetes mellitus	0.000126	0.000828	CcSEcCtD
Fluocinolone Acetonide—Infection—Losartan—type 2 diabetes mellitus	0.000125	0.000823	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000125	0.000821	CcSEcCtD
Fluocinolone Acetonide—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000125	0.0237	CrCbGaD
Fluocinolone Acetonide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000124	0.000812	CcSEcCtD
Fluocinolone Acetonide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000123	0.000807	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000122	0.000805	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000122	0.000802	CcSEcCtD
Fluocinolone Acetonide—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000122	0.0231	CrCbGaD
Fluocinolone Acetonide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000122	0.0008	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Glyburide—type 2 diabetes mellitus	0.00012	0.000789	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00012	0.000789	CcSEcCtD
Fluocinolone Acetonide—Rash—Glyburide—type 2 diabetes mellitus	0.000119	0.000783	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000119	0.000782	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000119	0.000782	CcSEcCtD
Fluocinolone Acetonide—Headache—Glyburide—type 2 diabetes mellitus	0.000118	0.000778	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000118	0.0223	CrCbGaD
Fluocinolone Acetonide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000116	0.000763	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000116	0.00076	CcSEcCtD
Fluocinolone Acetonide—Cough—Ramipril—type 2 diabetes mellitus	0.000115	0.000759	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000115	0.000755	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000115	0.000755	CcSEcCtD
Fluocinolone Acetonide—Pain—Irbesartan—type 2 diabetes mellitus	0.000114	0.000753	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000113	0.000746	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000113	0.0214	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000113	0.000741	CcSEcCtD
Fluocinolone Acetonide—Nausea—Glyburide—type 2 diabetes mellitus	0.000112	0.000737	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000112	0.000737	CcSEcCtD
Fluocinolone Acetonide—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000111	0.021	CrCbGaD
Fluocinolone Acetonide—Pruritus—Valsartan—type 2 diabetes mellitus	0.00011	0.000725	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000109	0.000716	CcSEcCtD
Fluocinolone Acetonide—Oedema—Ramipril—type 2 diabetes mellitus	0.000108	0.00071	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000108	0.000709	CcSEcCtD
Fluocinolone Acetonide—Pain—Losartan—type 2 diabetes mellitus	0.000108	0.000708	CcSEcCtD
Fluocinolone Acetonide—Rash—Gliclazide—type 2 diabetes mellitus	0.000107	0.000703	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000107	0.000702	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000107	0.000701	CcSEcCtD
Fluocinolone Acetonide—Headache—Gliclazide—type 2 diabetes mellitus	0.000106	0.000698	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000106	0.000697	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000106	0.000696	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000105	0.000692	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000103	0.000677	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000102	0.000669	CcSEcCtD
Fluocinolone Acetonide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000101	0.000662	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Metformin—type 2 diabetes mellitus	0.0001	0.00066	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Losartan—type 2 diabetes mellitus	9.96e-05	0.000655	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—NR3C1—type 2 diabetes mellitus	9.93e-05	0.0188	CrCbGaD
Fluocinolone Acetonide—Vomiting—Valsartan—type 2 diabetes mellitus	9.9e-05	0.000651	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.86e-05	0.000649	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.84e-05	0.000647	CcSEcCtD
Fluocinolone Acetonide—Rash—Valsartan—type 2 diabetes mellitus	9.82e-05	0.000646	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000645	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Orlistat—type 2 diabetes mellitus	9.78e-05	0.000644	CcSEcCtD
Fluocinolone Acetonide—Headache—Valsartan—type 2 diabetes mellitus	9.76e-05	0.000642	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Metformin—type 2 diabetes mellitus	9.7e-05	0.000638	CcSEcCtD
Fluocinolone Acetonide—Rash—Orlistat—type 2 diabetes mellitus	9.7e-05	0.000638	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000638	CcSEcCtD
Fluocinolone Acetonide—Headache—Orlistat—type 2 diabetes mellitus	9.64e-05	0.000634	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Irbesartan—type 2 diabetes mellitus	9.47e-05	0.000623	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Metformin—type 2 diabetes mellitus	9.38e-05	0.000617	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—NOS2—type 2 diabetes mellitus	9.35e-05	0.0177	CrCbGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.32e-05	0.000613	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.28e-05	0.00061	CcSEcCtD
Fluocinolone Acetonide—Nausea—Valsartan—type 2 diabetes mellitus	9.25e-05	0.000608	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000602	CcSEcCtD
Fluocinolone Acetonide—Nausea—Orlistat—type 2 diabetes mellitus	9.14e-05	0.000601	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Metformin—type 2 diabetes mellitus	9.02e-05	0.000593	CcSEcCtD
Fluocinolone Acetonide—Rash—Metformin—type 2 diabetes mellitus	8.94e-05	0.000588	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Metformin—type 2 diabetes mellitus	8.93e-05	0.000588	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Losartan—type 2 diabetes mellitus	8.91e-05	0.000586	CcSEcCtD
Fluocinolone Acetonide—Headache—Metformin—type 2 diabetes mellitus	8.88e-05	0.000584	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	8.87e-05	0.0168	CrCbGaD
Fluocinolone Acetonide—Dizziness—Irbesartan—type 2 diabetes mellitus	8.85e-05	0.000582	CcSEcCtD
Fluocinolone Acetonide—Budesonide—CYP3A4—type 2 diabetes mellitus	8.73e-05	0.0166	CrCbGaD
Fluocinolone Acetonide—Diarrhoea—Losartan—type 2 diabetes mellitus	8.62e-05	0.000567	CcSEcCtD
Fluocinolone Acetonide—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	8.56e-05	0.0162	CrCbGaD
Fluocinolone Acetonide—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000562	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.00056	CcSEcCtD
Fluocinolone Acetonide—Rash—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.000555	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Nausea—Metformin—type 2 diabetes mellitus	8.42e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Headache—Irbesartan—type 2 diabetes mellitus	8.38e-05	0.000551	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Losartan—type 2 diabetes mellitus	8.33e-05	0.000548	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—NR3C1—type 2 diabetes mellitus	8.3e-05	0.0157	CrCbGaD
Fluocinolone Acetonide—Betamethasone—NR3C1—type 2 diabetes mellitus	8.13e-05	0.0154	CrCbGaD
Fluocinolone Acetonide—Vomiting—Losartan—type 2 diabetes mellitus	8.01e-05	0.000527	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000523	CcSEcCtD
Fluocinolone Acetonide—Nausea—Irbesartan—type 2 diabetes mellitus	7.95e-05	0.000523	CcSEcCtD
Fluocinolone Acetonide—Rash—Losartan—type 2 diabetes mellitus	7.94e-05	0.000522	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Losartan—type 2 diabetes mellitus	7.93e-05	0.000522	CcSEcCtD
Fluocinolone Acetonide—Headache—Losartan—type 2 diabetes mellitus	7.89e-05	0.000519	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000503	CcSEcCtD
Fluocinolone Acetonide—Alclometasone—CYP3A4—type 2 diabetes mellitus	7.52e-05	0.0143	CrCbGaD
Fluocinolone Acetonide—Nausea—Losartan—type 2 diabetes mellitus	7.48e-05	0.000492	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000486	CcSEcCtD
Fluocinolone Acetonide—Flunisolide—CYP3A4—type 2 diabetes mellitus	7.32e-05	0.0139	CrCbGaD
Fluocinolone Acetonide—Paramethasone—CYP3A4—type 2 diabetes mellitus	7.23e-05	0.0137	CrCbGaD
Fluocinolone Acetonide—Dizziness—Ramipril—type 2 diabetes mellitus	7.14e-05	0.00047	CcSEcCtD
Fluocinolone Acetonide—Fluorometholone—CYP3A4—type 2 diabetes mellitus	7.06e-05	0.0134	CrCbGaD
Fluocinolone Acetonide—Vomiting—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000452	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	6.82e-05	0.0129	CrCbGaD
Fluocinolone Acetonide—Rash—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000448	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000447	CcSEcCtD
Fluocinolone Acetonide—Headache—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000445	CcSEcCtD
Fluocinolone Acetonide—Nausea—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000422	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—ABCC2—type 2 diabetes mellitus	6.2e-05	0.0118	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—CYP3A4—type 2 diabetes mellitus	5.75e-05	0.0109	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—type 2 diabetes mellitus	5.63e-05	0.0107	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SRD5A1—type 2 diabetes mellitus	5.26e-05	0.000754	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SOD1—type 2 diabetes mellitus	5.16e-05	0.00074	CbGpPWpGaD
Fluocinolone Acetonide—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	5.14e-05	0.00975	CrCbGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	5.02e-05	0.00072	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—STAR—type 2 diabetes mellitus	5.01e-05	0.000719	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSD17B3—type 2 diabetes mellitus	5.01e-05	0.000719	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ACACA—type 2 diabetes mellitus	5.01e-05	0.000719	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—GNB3—type 2 diabetes mellitus	4.99e-05	0.000716	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	4.94e-05	0.000708	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	4.92e-05	0.000706	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF2—type 2 diabetes mellitus	4.9e-05	0.000703	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	4.9e-05	0.000702	CbGpPWpGaD
Fluocinolone Acetonide—Prednisolone—CYP3A4—type 2 diabetes mellitus	4.81e-05	0.00912	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCC8—type 2 diabetes mellitus	4.81e-05	0.000689	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CBS—type 2 diabetes mellitus	4.81e-05	0.000689	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	4.79e-05	0.000688	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GCGR—type 2 diabetes mellitus	4.78e-05	0.000685	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOB—type 2 diabetes mellitus	4.76e-05	0.000682	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—NR3C1—type 2 diabetes mellitus	4.73e-05	0.00897	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	4.72e-05	0.000676	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—CYP3A4—type 2 diabetes mellitus	4.71e-05	0.00894	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—COX2—type 2 diabetes mellitus	4.63e-05	0.000664	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A2—type 2 diabetes mellitus	4.63e-05	0.000664	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—type 2 diabetes mellitus	4.61e-05	0.00875	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	4.6e-05	0.00066	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA6—type 2 diabetes mellitus	4.55e-05	0.000652	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.54e-05	0.000652	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	4.48e-05	0.000643	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSD11B1—type 2 diabetes mellitus	4.47e-05	0.000641	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—UCP2—type 2 diabetes mellitus	4.47e-05	0.000641	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—UCP3—type 2 diabetes mellitus	4.47e-05	0.000641	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GIPR—type 2 diabetes mellitus	4.39e-05	0.00063	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRK5—type 2 diabetes mellitus	4.39e-05	0.00063	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	4.39e-05	0.00063	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—CYP2E1—type 2 diabetes mellitus	4.35e-05	0.00826	CrCbGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	4.35e-05	0.000624	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.33e-05	0.000621	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CD36—type 2 diabetes mellitus	4.32e-05	0.000619	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	4.31e-05	0.000619	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PPP2CA—type 2 diabetes mellitus	4.26e-05	0.000611	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IAPP—type 2 diabetes mellitus	4.25e-05	0.000609	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PCK1—type 2 diabetes mellitus	4.2e-05	0.000603	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	4.15e-05	0.000595	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	4.14e-05	0.000593	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	4.14e-05	0.000593	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	4.12e-05	0.000591	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.11e-05	0.00059	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	4.11e-05	0.000589	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	4.09e-05	0.000587	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	4.06e-05	0.000582	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	4.04e-05	0.000579	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	4.03e-05	0.000578	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MC4R—type 2 diabetes mellitus	4.02e-05	0.000576	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	4.02e-05	0.000576	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	3.99e-05	0.000572	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	3.98e-05	0.000571	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	3.96e-05	0.000568	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	3.95e-05	0.000566	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MMP1—type 2 diabetes mellitus	3.94e-05	0.000564	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HK1—type 2 diabetes mellitus	3.93e-05	0.000564	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.93e-05	0.000564	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GIP—type 2 diabetes mellitus	3.87e-05	0.000555	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.84e-05	0.000551	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	3.83e-05	0.00055	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CALM1—type 2 diabetes mellitus	3.82e-05	0.000548	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—KCNJ11—type 2 diabetes mellitus	3.8e-05	0.000545	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCKR—type 2 diabetes mellitus	3.8e-05	0.000545	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPA—type 2 diabetes mellitus	3.8e-05	0.000545	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSD3B2—type 2 diabetes mellitus	3.8e-05	0.000545	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOA1—type 2 diabetes mellitus	3.76e-05	0.00054	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	3.74e-05	0.000536	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	3.73e-05	0.000535	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	3.73e-05	0.000535	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	3.7e-05	0.00053	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEPR—type 2 diabetes mellitus	3.68e-05	0.000527	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	3.66e-05	0.000525	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.65e-05	0.000524	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	3.65e-05	0.000523	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDOB—type 2 diabetes mellitus	3.64e-05	0.000522	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GHRL—type 2 diabetes mellitus	3.63e-05	0.000521	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PRKCB—type 2 diabetes mellitus	3.59e-05	0.000515	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CALCA—type 2 diabetes mellitus	3.59e-05	0.000515	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS2—type 2 diabetes mellitus	3.55e-05	0.000509	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.54e-05	0.000508	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	3.51e-05	0.000504	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.47e-05	0.000497	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.43e-05	0.000492	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TLE4—type 2 diabetes mellitus	3.42e-05	0.00049	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GLP1R—type 2 diabetes mellitus	3.39e-05	0.000486	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GCG—type 2 diabetes mellitus	3.32e-05	0.000477	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB3—type 2 diabetes mellitus	3.29e-05	0.000472	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	3.27e-05	0.000469	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.2e-05	0.000458	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	3.18e-05	0.000456	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A2—type 2 diabetes mellitus	3.16e-05	0.000453	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—type 2 diabetes mellitus	3.15e-05	0.000451	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT2—type 2 diabetes mellitus	3.14e-05	0.000451	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CPT1A—type 2 diabetes mellitus	3.1e-05	0.000444	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTR—type 2 diabetes mellitus	3.1e-05	0.000444	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	3.08e-05	0.000441	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NAMPT—type 2 diabetes mellitus	3.04e-05	0.000436	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.02e-05	0.000433	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LIPC—type 2 diabetes mellitus	3.02e-05	0.000433	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCK—type 2 diabetes mellitus	3.02e-05	0.000433	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HBA1—type 2 diabetes mellitus	3.02e-05	0.000433	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP11A1—type 2 diabetes mellitus	3e-05	0.00043	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—type 2 diabetes mellitus	2.99e-05	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	2.98e-05	0.000428	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—type 2 diabetes mellitus	2.98e-05	0.000428	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC9A1—type 2 diabetes mellitus	2.95e-05	0.000423	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.93e-05	0.000421	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CETP—type 2 diabetes mellitus	2.91e-05	0.000418	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.91e-05	0.000417	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.91e-05	0.000417	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.86e-05	0.000411	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.86e-05	0.00041	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—type 2 diabetes mellitus	2.85e-05	0.000409	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3R1—type 2 diabetes mellitus	2.85e-05	0.000409	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RBP4—type 2 diabetes mellitus	2.83e-05	0.000406	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	2.83e-05	0.000406	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.83e-05	0.000405	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.83e-05	0.000405	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.82e-05	0.000404	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2.79e-05	0.0004	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—CYP3A4—type 2 diabetes mellitus	2.74e-05	0.0052	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.72e-05	0.000389	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PSMD6—type 2 diabetes mellitus	2.71e-05	0.000388	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SREBF1—type 2 diabetes mellitus	2.71e-05	0.000388	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SNAP25—type 2 diabetes mellitus	2.71e-05	0.000388	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	2.69e-05	0.000385	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—type 2 diabetes mellitus	2.68e-05	0.00509	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CTGF—type 2 diabetes mellitus	2.66e-05	0.000381	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMGCR—type 2 diabetes mellitus	2.63e-05	0.000378	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.6e-05	0.000373	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.58e-05	0.00037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ADRA2A—type 2 diabetes mellitus	2.58e-05	0.00037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	2.55e-05	0.000366	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	2.54e-05	0.000365	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.54e-05	0.000365	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	2.52e-05	0.000362	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IAPP—type 2 diabetes mellitus	2.51e-05	0.00036	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INSR—type 2 diabetes mellitus	2.49e-05	0.000358	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2E1—type 2 diabetes mellitus	2.48e-05	0.000355	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.46e-05	0.000353	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.46e-05	0.000353	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.45e-05	0.000351	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1A2—type 2 diabetes mellitus	2.45e-05	0.000351	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A1—type 2 diabetes mellitus	2.45e-05	0.000351	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	2.45e-05	0.000351	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2.44e-05	0.000349	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.42e-05	0.000347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	2.4e-05	0.000345	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP3A4—type 2 diabetes mellitus	2.39e-05	0.000342	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.38e-05	0.000341	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—C3—type 2 diabetes mellitus	2.35e-05	0.000337	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCG—type 2 diabetes mellitus	2.35e-05	0.000337	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A4—type 2 diabetes mellitus	2.35e-05	0.000337	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.33e-05	0.000334	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.29e-05	0.000328	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.26e-05	0.000325	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.26e-05	0.000325	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.23e-05	0.00032	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.2e-05	0.000316	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.19e-05	0.000315	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.19e-05	0.000314	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.16e-05	0.000309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.15e-05	0.000308	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.15e-05	0.000308	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.12e-05	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SRC—type 2 diabetes mellitus	2.11e-05	0.000303	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	2.09e-05	0.0003	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.06e-05	0.000296	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—type 2 diabetes mellitus	2.06e-05	0.000295	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNB3—type 2 diabetes mellitus	2.02e-05	0.00029	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.02e-05	0.00029	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—type 2 diabetes mellitus	2.01e-05	0.000289	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2e-05	0.000286	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAT—type 2 diabetes mellitus	1.99e-05	0.000285	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.96e-05	0.000282	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.96e-05	0.000282	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	1.95e-05	0.00028	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.93e-05	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOB—type 2 diabetes mellitus	1.93e-05	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.93e-05	0.000276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—type 2 diabetes mellitus	1.89e-05	0.000271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—type 2 diabetes mellitus	1.88e-05	0.000269	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPL—type 2 diabetes mellitus	1.84e-05	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.84e-05	0.000263	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.8e-05	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ADCY5—type 2 diabetes mellitus	1.8e-05	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.8e-05	0.000258	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPX1—type 2 diabetes mellitus	1.8e-05	0.000258	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.78e-05	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CD36—type 2 diabetes mellitus	1.75e-05	0.000251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPP2CA—type 2 diabetes mellitus	1.73e-05	0.000248	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.71e-05	0.000245	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.69e-05	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.67e-05	0.000239	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.67e-05	0.000239	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.66e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—type 2 diabetes mellitus	1.66e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.65e-05	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.64e-05	0.000235	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARA—type 2 diabetes mellitus	1.63e-05	0.000233	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.61e-05	0.000231	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.61e-05	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.59e-05	0.000228	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AGT—type 2 diabetes mellitus	1.58e-05	0.000226	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.57e-05	0.000226	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CALM1—type 2 diabetes mellitus	1.55e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOE—type 2 diabetes mellitus	1.54e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPL—type 2 diabetes mellitus	1.54e-05	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA1—type 2 diabetes mellitus	1.53e-05	0.000219	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.51e-05	0.000216	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.48e-05	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.45e-05	0.000207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.42e-05	0.000204	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—C3—type 2 diabetes mellitus	1.39e-05	0.000199	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—type 2 diabetes mellitus	1.35e-05	0.000193	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.32e-05	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.32e-05	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—INS—type 2 diabetes mellitus	1.32e-05	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.32e-05	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—type 2 diabetes mellitus	1.31e-05	0.000188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.3e-05	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.29e-05	0.000185	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.29e-05	0.000185	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.28e-05	0.000183	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.22e-05	0.000176	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.22e-05	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—type 2 diabetes mellitus	1.21e-05	0.000173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.16e-05	0.000166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—type 2 diabetes mellitus	1.16e-05	0.000166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.15e-05	0.000165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INS—type 2 diabetes mellitus	1.1e-05	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.1e-05	0.000158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.09e-05	0.000156	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.07e-05	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.07e-05	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.06e-05	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—type 2 diabetes mellitus	1.06e-05	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.01e-05	0.000145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.67e-06	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.67e-06	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.11e-06	0.000131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.21e-06	0.000118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.16e-06	0.000117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.76e-06	0.000111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.68e-06	0.00011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.53e-06	0.000108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.16e-06	0.000103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.97e-06	9.99e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.4e-06	9.17e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.27e-06	8.99e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—type 2 diabetes mellitus	5.32e-06	7.63e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	4.84e-06	6.94e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.82e-06	6.91e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.45e-06	6.38e-05	CbGpPWpGaD
